Table 1.

Full information maximum likelihood (FIML) estimates (n = 361) of weekly means, standard deviations (SD), and weekly/cumulative effect sizes (ESsg) with 95% confidence intervals for self-efficacy, anxiety sensitivity, and panic disorder symptoms.

Outcome	Session	FIML estimates		Weekly change		Cumulative change
		Mean	SD	ESsg	95% CI	ESsg	95% CI
Self-efficacy	1	68.60	22.93	–	–	–	–
	2	69.33	22.94	.03	−.03:.09	.03	−.03:.09
	3	71.18	23.19	.08	.03:.13	.11	.05:.18
	4	73.46	22.63	.10	.05:.15	.21	.14:.28
	5	75.62	22.04	.09	.04:.15	.30	.23:.38
	6	77.63	20.47	.09	.05:.13	.40	.32:.48
	7	77.70	21.04	.00	−.03:.04	.40	.32:.49
	8	80.64	18.87	.14	.09:.18	.54	.45:.63
	9	82.72	18.98	.11	.06:.16	.63	.53:.73
	10	85.66	17.19	.15	.11:.18	.78	.67:.89
	11	87.29	17.20	.09	.06:.12	.87	.75:.98
Anxiety sensitivity	1	2.18	.73	–	–	–	–
	2	2.00	.72	−.25	−.19: −.30	−.25	−.19: −.30
	3	1.85	.73	−.21	−.16: −.27	−.46	−.38: −.53
	4	1.74	.79	−.13	−.08: −.19	−.57	−.48: −.66
	5	1.62	.81	−.15	−.10: −.19	−.72	−.61: −.82
	6	1.52	.78	−.13	−.08: −.18	−.87	−.75: −.98
	7	1.46	.80	−.07	−.03: −.11	−.93	−.81: −1.05
	8	1.35	.78	−.13	−.10: −.17	−1.09	−.96: −1.22
	9	1.29	.78	−.08	−.04: −.12	−1.17	−1.03: −1.31
	10	1.20	.76	−.12	−.07: −.16	−1.32	−1.17: −1.47
	11	1.10	.77	−.13	−.09: −.17	−1.45	−1.30: −1.61
Panic disorder symptoms	1	11.29	5.58	–	–	–	–
	2	10.36	5.20	−.16	−.09: −.23	−.16	−.09: −.23
	3	9.44	5.41	−.17	−.10: −.24	−.33	−.24: −.41
	4	9.20	5.45	−.04	.03: −.11	−.36	−.27: −.46
	5	8.10	5.49	−.20	−.13: −.28	−.57	−.46: −.67
	6	7.80	5.24	−.05	.03: −.13	−.63	−.52: −.73
	7	7.55	5.26	−.04	.03: −.11	−.67	−.56: −.78
	8	7.28	5.04	−.05	.02: −.12	−.73	−61: −.84
	9	6.57	4.89	−.14	−.06: −.21	−.86	−.74: −.99
	10	5.95	4.55	−.12	−.05: −.20	−1.01	−.87: −1.15
	11	5.16	4.60	−.18	−.10: −.25	−1.16	−1.02: −1.30

Note: Positive effect sizes indicate an increase during treatment, negative effect sizes indicate a decrease during treatment.